Scientists are increasingly finding that many diseases contain a genetic component. Some disorders result from mutations in a single gene, while others, complex diseases, arise from multiple factors. Genotyping enables researchers to explore the underlying genetic variants, including single nucleotide polymorphisms (SNPs) and large structural changes in DNA.
With multiple genomic targets potentially contributing to disease, analysis requires the use of flexible, accurate tools. High-throughput genomic technologies such as next-generation sequencing (NGS) and microarrays enable a deeper understanding of disease etiology on a molecular level, providing insight into the functional consequences of genetic variation.
Whole-genome genotyping enables interrogation of SNPs and other variants across the entire genome, providing researchers with the most comprehensive view of genomic variation.Learn More
Targeted genotyping enables researchers to focus time, effort, and resources on analyzing SNPs and other variants in a specific genomic region of interest, often with higher coverage.Learn More
Custom options allow researchers to focus on specific regions of the genome or to perform studies on regions or organisms for which standard products are not available.Learn More
Copy number variation (CNV) analysis involves detection of DNA copy number changes, as well as aberrant chromosome amplifications and deletions, relative to a reference genome.Learn More
Enhance the value of crops and herds with screening and discovery tools that aid in breeding decisions. Learn more about plant and animal genotyping.
Analyze germline mutations that predispose individuals to cancer using microarrays and next-generation sequencing. Learn more about cancer germline mutation studies.
Leverage biobank samples for translational, regenerative medicine, pharmacogenomic, clinical trial, epidemiology, and population studies. Learn more about biobank sample genotyping.
Screen large sample numbers quickly to find SNPs and other causal variants associated with complex diseases. Learn more about causal variant discovery.